| 14th Oct 2025 7:00 am |
RNS |
Full Year Results for the 12mths to 30 June 2025 |
| 13th Oct 2025 7:00 am |
RNS |
New contract with top 10 pharma |
| 10th Oct 2025 7:00 am |
RNS |
Notice of Results, Analyst & Investor Presentation |
| 8th Oct 2025 7:00 am |
RNS |
Major top 3 global pharma contract win |
| 26th Sep 2025 7:00 am |
RNS-R |
Investor Event and Presentation |
| 11th Sep 2025 7:00 am |
RNS-R |
New contract with Metir plc |
| 9th Sep 2025 7:00 am |
RNS |
Notification of dealings by a director/PDMR |
| 2nd Sep 2025 7:00 am |
RNS |
Therapeutic development agreement with Invizius |
| 28th Aug 2025 7:00 am |
RNS |
Block Listing Interim Review |
| 27th Aug 2025 7:00 am |
RNS |
Biomarker Discovery Service Launch |
| 22nd Aug 2025 7:00 am |
RNS |
Update on licensing and development progress |
| 19th Aug 2025 7:00 am |
RNS |
Exercise of warrants |
| 18th Aug 2025 3:44 pm |
RNS |
Holding(s) in Company |
| 18th Aug 2025 7:00 am |
RNS |
Contract extension with global pharma partner |
| 8th Aug 2025 7:00 am |
RNS-R |
Investor Technical Webinar |
| 7th Aug 2025 5:24 pm |
RNS |
Holding(s) in Company |
| 5th Aug 2025 8:05 am |
RNS |
Holding(s) in Company |
| 31st Jul 2025 1:29 pm |
RNS-R |
Investor Webinar |
| 31st Jul 2025 7:00 am |
RNS |
Trading Update |
| 28th Jul 2025 12:25 pm |
RNS |
Holding(s) in Company |
| 24th Jul 2025 11:48 am |
RNS |
Result of General Meeting |
| 21st Jul 2025 7:00 am |
RNS |
Additional work commissioned by Unilever |
| 18th Jul 2025 7:00 am |
RNS |
Issue of Equity in lieu of Non-Exec Director Fees |
| 9th Jul 2025 2:53 pm |
RNS |
Holding(s) in Company |
| 8th Jul 2025 7:00 am |
RNS |
Posting of Circular and Notice of General Meeting |
| 4th Jul 2025 7:00 am |
RNS |
Placing to raise £2.0 million |
| 30th Jun 2025 7:00 am |
RNS |
Liver fibrosis breakthrough with Optimer® platform |
| 25th Jun 2025 7:00 am |
RNS |
Agreement with global life sciences leader |
| 30th May 2025 7:00 am |
RNS |
Unilever second Optimer development programme |
| 15th May 2025 7:01 am |
RNS |
Aptamer Announces New Data at ASGCT |
| 15th May 2025 7:00 am |
RNS |
Optimer licensing agreements and repeat contracts |
| 6th May 2025 7:00 am |
RNS |
Alzheimer’s test advanced and royalty agreement |
| 30th Apr 2025 7:00 am |
RNS |
Licensing agreed for Optimer as vaccine adjuvant |
| 29th Apr 2025 7:00 am |
RNS-R |
Aptamer Presenting at ASGCT Annual Meeting |
| 24th Apr 2025 7:00 am |
RNS-R |
New Corporate Presentation and Investor Factsheet |
| 11th Mar 2025 7:00 am |
RNS |
Interim Results |
| 27th Feb 2025 12:50 pm |
RNS |
TR-1: Standard form notification of major holdings |
| 25th Feb 2025 7:01 am |
RNS |
Block Listing Interim Review |
| 25th Feb 2025 7:00 am |
RNS |
Notice of Results and Investor Presentation |
| 28th Jan 2025 2:56 pm |
RNS |
Issue of Equity in lieu of Director fees |
